FR3117802A1 - Transparent antiperspirant and/or deodorant micellar water - Google Patents

Abstract

Transparent antiperspirant and/or deodorant micellar water The present invention relates to a transparent aqueous micellar antiperspirant and/or deodorant composition comprising: - some water - at least one antiperspirant and/or deodorant active ingredient; And - at least one surfactant. It also relates to a method of cosmetic treatment of body odors linked to human perspiration, in particular axillary odors, and possibly human perspiration, consisting of applying to the surface of the skin, in particular in the form of a spray, in particular to the using a pump or spray bottle, an effective quantity of the cosmetic composition according to the invention, in particular without greenhouse gas emissions. Figure for abstract: Figure 3

Description

Transparent antiperspirant and/or deodorant micellar water

The present invention relates to a micellar water comprising an antiperspirant and/or deodorant active ingredient, as well as a deodorant and/or antiperspirant cosmetic process for human keratin materials, preferably the skin, using this composition.

Background of the invention

In the field of cosmetic products, it is well known to use topical application of antiperspirant and/or deodorant products containing substances which have the effect of respectively limiting the flow of perspiration and the development of malodor. The antiperspirant and/or deodorant effect is hereafter abbreviated as AT/DO effect.

In the field of deodorants and antiperspirants, there are many galenic forms: stick, roll-on, cream, aerosol or spray/vaporizer, giving consumers a wide choice. Their evaluations focus mainly on the application and the sensation perceived by the consumer. For this, the objective is to formulate a product with sufficient AT/DO efficiency, presenting on application a minimum drying time and a feeling of lightness, and leaving no visible stains on the clothes.

While solid or creamy formulas most often use roll-on or stick type contact dosage forms, AT/DO formulas in liquid form, generally in aerosol or spray form, are more pleasant and easier to apply, in particular because they avoid direct contact of the skin with a dispensing tip, and can be perceived as more hygienic.

The aerosol type dosage form is one of the most used forms in the deodorant and antiperspirant sector. An aerosol formulation is a suspension of particles or liquid in a liquefied or compressed gas, the “propellant”. A spray from an "aerosol" is characterized by its sensoriality (softness, strength, dry touch), its flow rate, its spray angle, the size of the particles and its precision.

In cosmetics, the propellants still used are liquefied and hydrocarbon in nature. To allow complete homogenization of the formula and the hydrocarbons present, it is recommended to shake the bottle before use. The consumer can thus benefit from a homogeneous juice/gas product throughout the life of the product. This gesture is necessary to allow a product to be kept with the same effectiveness between its first and its last use, and also makes it possible to prevent the risk of clogging of the aerosol device, after spraying following the drying of particles that are not sufficiently dispersed.

For the sake of sustainable development, we seek to design cosmetic products whose manufacture, marketing and use generate the least possible impact on the environment, in particular by reducing the emission of greenhouse gases. There is therefore a real need to develop AT/DO aerosol formulas propelled, not by hydrocarbons in the form of liquefied gases, but by compressed air.

There are already compressed air aerosol products in the cosmetics field, in particular alcoholic deodorants with air as a propellant gas, or which use Bag-on-Valve technology (known as BOV for "Bag on Valve"). ) and offer a deodorant without petroleum gas (butane, propane). Currently, there is no antiperspirant aerosol propelled by compressed air on the market, nor any rheological antiperspirant formula suitable for this type of distribution. Moreover, the liquid formulas of conventional vaporizer/non-aerosol spray formulations comprising a deodorant and/or antiperspirant active ingredient are known for their tendency to run on the skin after application and to exhibit a sticky effect.

There is therefore a real need to develop an AT/DO liquid composition that can be sprayed into fine droplets, in particular by means of an aerosol with the most natural propulsion possible, in particular with compressed air, or by means of a sprayer conventional, such as those commonly used in perfumery, and which is both stable and without the risk of clogging the aerosol, while meeting consumer requirements in terms of efficacy and sensoriality, with a non-wetting, non-wetting deposit sticky and quick drying, for a dry and fresh effect. The present invention also aims to provide a sprayable antiperspirant composition, in particular propellable with a gas (air or nitrogen) compressed (continuous spray) or sprayable by means of a conventional pump (discontinuous spray), and without sticky effect .

The Applicant has discovered, surprisingly, that all of these objectives can be achieved by the transparent aqueous micellar composition according to the present invention.

According to a first aspect, the subject of the present invention is a transparent aqueous micellar antiperspirant and/or deodorant composition comprising:

- some water

- at least one antiperspirant and/or deodorant active ingredient; And

- at least one surfactant.

The composition of the invention is advantageously in the form of a transparent and colorless micellar water, preferably having the same appearance as water, and in particular the same texture as liquid water at ambient temperature conditions (25 °C) and pressure (100 kPa).

In addition, said micellar composition advantageously contains free micelles, detectable in particular by "dynamic light scattering" DLS spectroscopic analysis based on the principle of dynamic light scattering, said micelles preferably having a median diameter D50 in the range from 10 to 50 n.

Advantageously, the content by weight of said at least one surfactant in the composition corresponds to a concentration of said at least one surfactant in the composition greater than the critical micellar concentration (CMC) of said at least one surfactant in the composition, said CMC being preferably determined by tensiometry.

Since the composition of the invention is a transparent micellar water, its content of fatty substances, in particular of fatty substances that are liquid at room temperature (25° C.), such as oil, if the composition contains it, advantageously does not exceed 2 % by weight, preferably does not exceed 1% by weight, preferably does not exceed 0.5% by weight, preferably does not exceed 0.2% by weight, on the total weight of the composition, preferably the composition being devoid, or even completely free of fatty substances, in particular liquid, such as oil; this in particular so as not to create an emulsion which could negatively impact the colorless transparent appearance of the micellar water of the invention.

According to a second aspect, the subject of the present invention is an antiperspirant and/or deodorant cosmetic product comprising a bottle containing an aqueous micellar composition according to the invention, and a dispensing pump and/or a spraying device intended to dispense said aqueous micellar composition in the form of a spray, in particular without greenhouse gas emission from a liquefied hydrocarbon; said bottle preferably being transparent, preferably made of glass or plastic, such as PET.

According to a third aspect, the subject of the present invention is a method for the cosmetic treatment of body odors linked to human perspiration, in particular underarm odors, and possibly human perspiration, consisting in applying to the surface of the skin, in particular under in the form of a spray, in particular using a pump or spray bottle, an effective quantity of the cosmetic composition as defined according to the invention, in particular without emitting greenhouse gases. Furthermore, said method may comprise the agitation of a composition according to the invention before its application, preferably by spraying or spraying, to the surface of the skin.

Detailed description of the invention

Within the meaning of the present invention, and unless a different indication is given:

The term "micellar" means a composition, in particular aqueous, which contains free micelles, detectable in particular by DLS "dynamic light scattering" spectroscopic analysis based on the principle of dynamic light scattering, said micelles preferably having a median diameter D50 included in the range of 10 to 50 nm.

The term "micellar" also means a composition, in particular aqueous, in which the content by weight of said at least one surfactant in the composition corresponds to a concentration of said at least one surfactant in the composition greater than the critical micellar concentration (CMC) of said at least one least one surfactant in the composition, said CMC being preferably determined by tensimetry.

Micellarity can be detected by light scattering measurements known in the state of the art. The DLS (Dynamic Light Scattering) technique can be used and makes it possible to see if the D50 of the "micelles" is in the 10-50 nm range.

The tensiometry technique makes it possible to determine the CMC (Critical Micelle Concentration).

In the context of the invention, and unless otherwise stated, the term “deodorant active” or “deodorant agent”, hereinafter active “DO”, means any substance capable of masking, absorbing, improving and/or reducing the odor unpleasant resulting from the decomposition of human sweat by bacteria.

In the context of the invention, and unless otherwise stated, the term “antiperspirant active” or “antiperspirant agent”, hereinafter active “AT”, means a molecule which, on its own, has the effect of decrease the flow of sweat, decrease the sensation on the skin of humidity linked to human sweat.

The composition according to the invention is a cosmetic composition, i.e. found in a cosmetic medium.

The method of the invention is particularly advantageous for treating body odor associated with perspiration in the armpits.

The compositions, in particular cosmetics, according to the invention comprise a physiologically acceptable medium. Within the meaning of the present invention, the term "physiologically acceptable medium" is intended to denote a medium suitable for administering a composition to the skin. A physiologically acceptable medium is generally odorless, or unpleasant in appearance, and is perfectly compatible with the topical route of administration on the skin. In the present case where the composition is intended to be administered by application to the surface of the skin, such a medium is in particular considered to be physiologically acceptable when it does not generate any tingling, tightness or redness that is unacceptable for the user.

In particular, the composition is suitable for application to the surface of the skin. Thus, the physiologically acceptable medium is preferably a cosmetically or dermatologically acceptable medium, that is to say without unpleasant odor, color or appearance, and which does not generate any tingling, tightness or redness that is unacceptable for the user.

The composition can then comprise all the constituents usually employed in the application envisaged. Of course, those skilled in the art will take care to choose this or these optional additional compounds, and/or their quantity, in such a way that the advantageous properties of the compounds according to the invention are not, or substantially not, altered by the addition considered.

Other characteristics, aspects and advantages of the invention will appear on reading the detailed description which follows.

In the context of the present invention, the term "devoid of" indicates that the composition comprises less than 0.5% by weight, even less than 0.2% by weight, and even more particularly less than 0.1% by weight of the compound concerned, relative to the total weight of the composition. Preferably the composition is free of the compound concerned.

Within the meaning of the present invention, and unless a different indication is given, the expression "at least one" is equivalent to "one or more" and, unless otherwise indicated (such as “more than…”, “less than” or “between X and Y”), the limits of a domain of values are included in this domain (for example “in the range of X to Y”).

Composition

According to a first aspect, the subject of the present invention is an aqueous micellar composition or “micellar water” AT/DO as defined above.

The Applicant has found that, surprisingly, the addition of one or more surfactants in a particular concentration greater than their CMC in an aqueous composition comprising one or more AT/DO agents made it possible to stabilize the AT/DO active(s) and to obtain a satisfactory level of AT/DO efficiency as well as better spraying, in particular by means of a compressed air aerosol or a conventional sprayer, with interesting sensory properties of a dry, fresh and non-sticky effect after application.

The micellarity of the composition according to the invention provides many advantages as demonstrated in the examples below: a shorter total drying time (maximum 20 minutes), the film deposited on the skin after spraying with a compressed air aerosol is flexible after drying (that is to say neither rigid nor brittle), the film does not run (that is to say it has a gripping power greater than 100 seconds).

The AT/DO formula of the invention is perceived (sensory test) as effective for the AT/DO effect, without sticky effect, and more natural than the current AT/DO formulas on the market.

The transparency of the formula is another advantage for consumers, who appreciate the clean and fresh effect of this new galenic micellar water.

The total content of surfactants in the composition of the invention is preferably less than 10%, preferably less than 8%, or even in certain cases less than 5%, by weight relative to the total weight of the composition, provided that it is always possible the micellarity of the composition.

Aqueous composition

The term “aqueous composition” means a composition comprising water and in general any molecule in the dissolved state in the water in the composition. Preferably, the aqueous composition is an aqueous solution.

Optionally, it may also comprise other water-soluble or water-miscible solvents. Water-soluble or water-miscible solvents include short-chain monoalcohols, for example C1-C4, such as ethanol, isopropanol; diols or polyols such as ethylene glycol, 1,2-propylene glycol, 1,3-butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol (or 1,2-octanediol), diethylene glycol, dipropylene glycol, 2-ethoxyethanol, diethylene glycol monomethyl ether, triethylene glycol monomethyl ether and sorbitol. More particularly, ethanol, hexylene glycol and/or caprylyl glycol are used.

The aqueous composition according to the invention mainly contains water, that is to say more than 50% by weight of water, on the total weight of the composition.

Preferably, the water is present in a content of at least 55% by weight relative to the total weight of aqueous composition, preferably at least 60% by weight, preferably at least 65% by weight, preferably at least 70% by weight, preferably at least 75% by weight, preferably at least 80% by weight, preferably at least 85% by weight, preferably at least 90% by weight, preferably at least 92% by weight.

The aqueous micellar composition of the invention preferably comprises water in a content ranging from 55% to 99% by weight, preferably from 60% to 95%, preferably from 65% to 95%, preferably from 70 % to 95%, preferably from 75% to 95%, preferably from 80% to 95%, more preferably from 85% to 95%, or even from 90 to 95% by weight relative to the total weight of the aqueous micellar composition AT/DO representing 100%.

The AT/DO aqueous micellar composition according to the invention comprises at least one deodorant and/or antiperspirant active ingredient.

Active antiperspirants

The antiperspirant active agents according to the present invention are advantageously chosen from antiperspirant salts or complexes.

Among the antiperspirant active agents, mention may advantageously be made of antiperspirant salts or complexes of aluminum and/or of zirconium.

For this purpose, mention may be made of aluminum halohydrates; aluminum and zirconium halohydrates, zirconium hydroxychloride and aluminum hydroxychloride complexes with or without an amino acid such as those described in patent US3792068, aluminum chlorohydrex aluminum chlorohydrex complex aluminum chlorohydrex polyethylene glycol complex, aluminum chlorohydrex propylene glycol complex, aluminum dichlorohydrate, aluminum dichlorohydrex polyethylene glycol complex, aluminum dichlorohydrex propylene glycol complex, aluminum sesquichlorohydrate, aluminum sesquichlorohydrex polyethylene glycol complex, aluminum sesquichlorohydrex propylene glycol complex, buffered aluminum sulfate by sodium and aluminum lactate.

Among the aluminum and zirconium salts, mention may be made in particular of aluminum zirconium octachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium trichlorohydrate.

Complexes of zirconium hydroxychloride and aluminum hydroxychloride with an amino acid are generally known as ZAG (when the amino acid is glycine).

Among these products, mention may be made of the aluminum zirconium octachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine and aluminum zirconium trichlorohydrex glycine complexes.

Aluminum sesquichlorohydrate is in particular sold under the trade name REACH 301® by the company SUMMITREHEIS.

Among the aluminum and zirconium complexes, mention may be made of the complexes of zirconium hydroxychloride and aluminum hydroxychloride with an amino acid such as glycine having the INCI name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY, for example that marketed under the name REACH AZP-908-SUF® by SUMMITREHEIS company.

Use will more particularly be made of the aluminum chlorohydrate marketed under the trade names LOCRON S FLA®, LOCRON P, LOCRON L.ZA by the company CLARIANT; under the trade names MICRODRY ALUMINUM CHLOROHYDRATE®, MICRO-DRY 323®, CHLORHYDROL 50, REACH 103, REACH 501 by the company SUMMITREHEIS; under the trade name WESTCHLOR 200® by the company WESTWOOD; under the trade name ALOXICOLL PF 40® by the company GUILINI CHEMIE; CLURON 50%® by the company INDUSTRIA QUIMICA DEL CENTRO; CLOROHIDROXIDO ALUMINIO SO A 50%® by FINQUIMICA.

According to a particular embodiment, the antiperspirant active ingredient comprises aluminum chlorhydrate.

The antiperspirant salts or complexes, which may be in the form of mixtures of the salts and/or complexes described above, may be present in the aqueous composition in a proportion of 1 to 40% by weight, preferably from 1 to 30 % by weight, preferably from 5 to 30% by weight, for example from 6 to 28% by weight, for example from 7 to 25% by weight of active material, relative to the total weight of the aqueous composition.

Preferably, the antiperspirant active ingredient is present in the composition at a rate of 1 to 40% by weight, preferably 1 to 30% by weight, preferably 5 to 25% by weight, preferably 5 to 20 % by weight, preferably from 7 to 15% by weight of active material relative to the total weight of the composition.

Deodorant active ingredients

The aqueous composition may also contain at least one deodorant active ingredient.

The deodorant active agents may be present in the aqueous composition at a rate of 1 to 30% by weight of active material relative to the total weight of aqueous composition, and preferably at a rate of 1 to 20%, preferably from 1 to 10% by weight of active ingredient on the total weight of the composition.

Among the deodorant active ingredients, we can mention:

- antibacterial, bacteriostatic or bactericidal agents, such as:

2,4,4'-trichloro-2'-hydroxydiphenyl ether (Triclosan),

2,4-dichloro-2'-hydroxydiphenyl ether,

3',4',5'-trichlorosalicylanilide,

1-(-3',4'-dichlorophenyl)-3-(4'chlorophenyl)urea (Triclocarban)

or 3,7,11-trimethyldodeca-2,5,10-trienol (Farnesol);

quaternary ammonium salts such as cetyltrimethylammonium salts, cetylpyridinium salts;

chlorhexidine and salts;

polyhexamethylene biguanide salts;

salicylic acid, its salts and its derivatives;

triethylcitrate, biguanide, polylysine, caprylhydroxamic acid, ethylzingerone, tromethamine;

NH2 acetate salts of palmitoyl lisine histidine / proline / arginine,

ethyl lauroyl arginate hydrochloride;

- alcohols, such as caprylyl glycol, polyhydroxyamines (aminopropanediols), ethyl hexyl glycerine, ethanol, 2-methyl 5-cyclohexylpentanol, 4-(1-phenylethyl)-1,3-benzenediol;

- zinc salts such as zinc salicylate, zinc phenolsulfonate, zinc pyrrolidone carboxylate (more commonly known as zinc pidolate), zinc sulfate, zinc chloride, zinc lactate, zinc gluconate, zinc ricinoleate, zinc glycinate, zinc carbonate, zinc citrate, zinc chloride, zinc laurate, zinc oleate, zinc orthophosphate, zinc stearate, zinc tartrate zinc, zinc lactate, zinc acetate or mixtures thereof;

- polymers such as polyvinylamine, polyethyleneimine, lauryl methacrylate/glycol dimethacrylate copolymer;

- other inorganic salts, such as sodium hydrogen carbonate NaHCO3, calcium hydroxide Ca(OH)2;

- odor absorbers such as zeolites, cyclodextrins, metal oxide silicates such as those described in application US2005/063928; chitosan derivatives such as those described in patent US6916465;

- substances blocking the enzymatic reactions responsible for the formation of odorous compounds such as triethyl citrate, arylsulfatase, 5-Lipoxygenase, aminocyclase and β-glucoronidase inhibitors;

- essential oils, in particular deodorants,

- extracts, such as usnea barbata extract

- and mixtures thereof.

Among the essential oils that can be used according to the invention, mention may be made of those obtained from plants belonging to the following botanical families:

Abietaceae or Pinaceae: conifers; Amaryllidaceae; Anacardiaceae; Anonaceae: ylang; Apiaceae (e.g. Umbelliferae): dill, angelica, coriander, samphire, carrot, parsley; Araceae; Aristolochiaceae; Asteraceae: yarrow, mugwort, chamomile, helichrysum; Betulaceae; Brassicaceae; Burseraceae: frankincense; Caryophyllaceae; Canellaceae; Caesalpiniaceae: copaïfera (copahu); Chenopodaceae; Cistaceae: cistus; Cyperaceae; Dipterocarpaceae; Ericaceae: wintergreen (wintergreen); Euphorbiaceae; Fabaceae; Geraniaceae: geranium; Guttiferae; Hamamelidaceae; Hernandiaceae; Hypericaceae: St. John's wort; Iridaceae; Juglandaceae; Lamiaceae: thyme, oregano, monarda, savory, basil, marjoram, mint, patchouli, lavender, sage, catnip, rosemary, hyssop, lemon balm; Lauraceae: ravensara, laurel, rosewood, cinnamon, litsea; Liliaceae: garlic; Magnoliaceae: magnolia; Malvaceae; Meliaceae; Monimiaceae; Moraceae: hemp, hops; Myricaceae; Mysristicaceae: nutmeg; Myrtaceae: eucalyptus, tea tree, niaouli, cajeput, backousia, clove, myrtle; Oleaceae; Piperaceae: pepper; Pittosporaceae; Poaceae: lemongrass, lemongrass, vetiver; Polygonaceae; Ranunculaceae; Rosaceae: roses; Rubiaceae; Rutaceae: all citrus; Salicaceae; Santalaceae: sandalwood; Saxifragaceae; Schisandraceae; Styracaceae: benzoin; Thymelaceae: agarwood; Tilliaceae; Valerianaceae: valerian, nard; Verbenaceae: lantana, verbena; Purplish; Zingiberaceae: galangal, turmeric, cardamom, ginger; or Zygophyllaceae.

We can also mention essential oils extracted from flowers (lily, lavender, rose, jasmine, Ylang-Ylang, neroli), stems and leaves (patchouli, geranium, petitgrain), fruits (coriander, anise, cumin, juniper), fruit peels (bergamot, lemon, orange), roots (angelica, celery, cardamom, iris, sweet flag, ginger), wood (pine wood, sandalwood, guaiac wood, pink cedar, camphor), d herbs and grasses (tarragon, rosemary, basil, lemon grass, sage, thyme), needles and branches (spruce, fir, pine, dwarf pine), resins and balms (galbanum, elemi, benzoin, myrrh , olibanum, opopanax).

The essential oil preferably used in the micellar compositions according to the invention is chosen from essential oil of mint, in particular peppermint, essential oil of geranium, essential oil of citronella, essential oil of cedar, sweet orange essential oil, green oregano essential oil, lemongrass essential oil, lemon catnip essential oil, rosemary essential oil, mountain savory essential oil , essential oil of lemon savory, essential oil of laser siler (Apiaceae, seeds or leaves), essential oil of marjoram, essential oil of bupleurum (Asteraceae), essential oil of deodorant yarrow, essential oil of thyme, essential oil of lemon balm, essential oil of lemon, essential oil of eucalyptus, in particular radiata or globulus, essential oil of green or red mandarin, essential oil of clove, esse oil cinnamon extract and mixtures thereof. Preferably, it is chosen from essential oil of mint, in particular peppermint, essential oil of geranium, essential oil of citronella, essential oil of green oregano, essential oil of lemongrass, essential oil of lemon catnip, essential oil of rosemary, essential oil of mountain savory, essential oil of lemon savory, essential oil of thyme, essential oil of lemon balm, essential oil of cloves and mixtures thereof.

When oils, such as essential oils, are present in the composition of the invention, their content is preferably in the range from 0.001% to 2%, preferably from 0.01 to 1.5%; these maximum contents of oils, in particular essential oils, being advantageously limited to 2% or even 1%, to guarantee the transparency of the composition according to the invention.

Surfactants

The composition according to the present invention comprises at least one surfactant.

As surfactants suitable for the present invention, mention may in particular be made of nonionic surfactants, anionic surfactants, amphoteric or zwitterionic surfactants.

Advantageously, the surfactant in total is present in the composition according to the present invention in a content ranging from 0.1% by weight to 20% by weight, preferably from 0.2% by weight to 10% by weight, more preferably from 0.5% by weight. at 8% by weight relative to the total weight of the composition.

Nonionic surfactants

The nonionic surfactants can be chosen from alcohols, α-diols and (C1-20) alkylphenols, these compounds being polyethoxylated and/or polypropoxylated and/or polyglycerolated, the number of ethylene oxide and/or oxide propylene which can range from 1 to 100, and the number of glycerol groups which can range from 2 to 30; and/or these compounds comprising at least one fatty chain comprising from 8 to 30 carbon atoms and in particular from 16 to 30 carbon atoms.

According to the present invention, it is possible in particular to use surfactants having, at 25° C., an HLB balance (hydrophilic-lipophilic balance), within the meaning of Griffin, greater than or equal to 8, more particularly an HLB greater than or equal to 10, of preferably greater than or equal to 13, used alone or as a mixture.

The HLB value according to Griffin is defined in J. Soc. cosm. Chem., 1954 (volume 5), pages 249-256.

We can mention in particular:

- monosaccharide esters and ethers, such as the mixture of cetylstearyl glucoside and cetyl and stearyl alcohols, for example Montanov 68 from Seppic;

- oxyethylenated and/or oxypropylene ethers (which may comprise from 1 to 150 oxyethylene and/or oxypropylene groups) of glycerol; oxyethylenated and/or oxypropylene ethers (which may comprise from 1 to 150 oxyethylene and/or oxypropylene groups) of fatty alcohols (in particular of C8-C24 and preferably C12-C18 alcohols), such as oxyethylenated ether cetearyl alcohol comprising 30 oxyethylene groups (CTFA name "Ceteareth-30"), the oxyethylenated ether of stearyl alcohol comprising 20 oxyethylene groups (CTFA name "Steareth-20") and the oxyethylenated ether of the mixture of alcohols fatty C12-C15 comprising 7 oxyethylene groups (CTFA name "012-15 Pareth-7"), marketed under the name Neodol 25-7® by Shell Chemicals;

- fatty acid esters (in particular of C8-C24 and preferably C16-C22 acid) and of polyethylene glycol (which may comprise from 1 to 150 ethylene glycol units), such as PEG-50 stearate and PEG monostearate -40, marketed under the name Myrj 52P® by ICI Uniquema;

- fatty acid esters (in particular of C8-C24 and preferably C16-C22 acid) and of oxyethylenated and/or oxypropylene glycerol ethers (which may comprise from 1 to 150 oxyethylene and/or oxypropylene groups), such as that PEG-200 glyceryl monostearate, sold under the name Simulsol 220 ™ ® by Seppic; polyethoxylated glyceryl stearate comprising 30 ethylene oxide groups, such as the product Tagat S® marketed by Goldschmidt, polyethoxylated glyceryl oleate comprising 30 ethylene oxide groups, such as the product Tagat 0® marketed by Goldschmidt, cocoate of polyethoxylated glyceryl comprising 30 ethylene oxide groups, such as the Varionic LI 13® product marketed by Sherex, polyethoxylated glyceryl isostearate comprising 30 ethylene oxide groups, such as the Tagat L® product marketed by Goldschmidt, and laurate polyethoxylated glyceryl comprising 30 ethylene oxide groups, such as the product Tagat 1® from Goldschmidt; fatty acid esters (in particular of C8-C24 and preferably C16-C22 acid) and oxyethylenated and/or oxypropylene sorbitol ethers (which may contain from 1 to 150 oxyethylene and/or oxypropylene groups), commonly called "carbohydrate esters (CBE)". Examples of said esters based on carbohydrates, but not limited to, are such as polysorbate 20, sold under the name Tween20® by Croda, polysorbate 21, sold under the name Tween21® by Croda or polysorbate 60, sold under the name Tween60® by Croda; dimethicone copolyol such as that sold under the name Q2-5220® by Dow Corning; dimethicone copolyol benzoate (Finsolv SLB 101® and 201® from Fintex). Examples of such surfactants are provided in US 2012/042894, which is incorporated herein by reference.

Preferably, the nonionic surfactants are chosen from block copolymer surfactants, also called polycondensate surfactants of ethylene oxide and propylene oxide and more particularly a copolymer consisting of polyethylene glycol and polypropylene glycol blocks, such as for example polyethylene glycol polypropylene glycol / polyethylene glycol triblock block copolymers (polycondensates). These triblock polycondensates have for example the following chemical structure:

H—(O—CH ₂ —CH ₂ ) _a —(O—CH(CH ₃ )—CH ₂ ) _b —(O—CH ₂ —CH ₂ ) _a —OH

wherein formula a is 2 to 150 and b is 1 to 100; preferably, a ranges from 10 to 130 and b ranges from 20 to 80.

The block copolymer surfactant (polycondensate) of ethylene oxide and propylene oxide preferably has a weight-average molecular weight ranging from 1000 to 20000, better still ranging from 1500 to 19000, in particular ranging from 2000 to 18000 and even better ranging from 4000 to 17000.

As surfactant block copolymer (polycondensate) of ethylene oxide and propylene oxide that can be used according to the present invention, mention may be made of the polyethylene glycol/polypropylene glycol/polyethylene glycol triblock polycondensates marketed under the names “Synperonic”, such as than “Synperonic® PE/F32” (INCI name: Poloxamer 108), “Synperonic® PE/F108” (INCI name: Poloxamer 338), “Synperonic® PE/L44” (INCI name: Poloxamer 124), “Synperonic® PE /L42” (INCI name: Poloxamer 122), “Synperonic® PE/F127” (INCI name: Poloxamer 407), “Synperonic® PE/F88” (INCI name: Poloxamer 238) or “Synperonic® PE/L64” (Inci INCI: Poloxamer 184 from Croda or “Lutrol® F68” (INCI name: Poloxamer 188), marketed by BASF

Advantageously, the nonionic surfactant, when it is present in the composition according to the present invention, represents a content ranging from 0.01% by weight to 10% by weight, preferably from 0.1% by weight to 5% by weight. , more preferably from 0.2% by weight to 2% by weight, relative to the total weight of the composition.

Anionic surfactants

By “anionic surfactant” is meant a surfactant comprising, as ionic or ionizable groups, only anionic groups.

In the present description, a species is said to be "anionic" when it carries at least one permanent negative charge or when it can be ionized into a negatively charged species, under the conditions of use of the composition of the invention (for example the medium or the pH) and comprising no cationic charge.

Said anionic surfactants are preferably chosen from sulphonate surfactants and carboxylate surfactants. It goes without saying that a mixture of these surfactants can be used.

It is understood in this description that:

- the carboxylate anionic surfactants comprise at least one carboxylic or carboxylate function (-COOH or -COO-) and may optionally also comprise one or more sulphate and/or sulphonate functions;

- the sulphonate anionic surfactants comprise at least one sulphonate function (-SO3H or -SO3–) and may optionally also comprise one or more sulphate functions, but do not comprise carboxylate functions.

The carboxylic anionic surfactants which can be used thus comprise at least one carboxylic or carboxylate function (-COOH or -COO-).

They can be chosen from the following compounds: acyllactylates, alkyl ether carboxylic acids, alkyl (C6-C30 aryl) ether carboxylic acids, as well as the salts of these compounds;

the alkyl and/or acyl groups of these compounds comprising from 6 to 30 carbon atoms, in particular from 12 to 28, better still from 14 to 24 or even from 16 to 22 carbon atoms; the aryl group preferably designating a phenyl or benzyl group; these compounds possibly being polyoxyalkylenated, in particular polyoxyethylenated, and then preferably comprising from 1 to 50 ethylene oxide units, better still from 2 to 10 ethylene oxide units.

The sulphonate anionic surfactants that can be used comprise at least one sulphonate function (-SO3H or -SO3 ^– ).

They can be chosen from the following compounds: alkylsulphonates, alkylarylsulphonates, paraffin sulphonates, alkylsulphosuccinates, alkyl ether sulphosuccinates, alkylsulphoacetates, N-acyltaurates, acylisethionates; alkylsulfolaurates; as well as the salts of these compounds;

the alkyl groups of these compounds comprising from 6 to 30 carbon atoms, in particular from 12 to 28, better still from 14 to 24 or even from 16 to 22 carbon atoms; the aryl group preferably designating a phenyl or benzyl group;

these compounds possibly being polyoxyalkylenated, in particular polyoxyethylenated, and then preferably comprising from 1 to 50 ethylene oxide units and better still from 2 to 10 ethylene oxide units.

When the anionic surfactant is in the form of a salt, said salt may be chosen from alkali metal salts, such as sodium or potassium salt, ammonium salts, amine salts and in particular salts of amino alcohols, and alkaline earth metal salts, such as magnesium salt. As examples of salts of amino-alcohols, mention may be made of the salts of monoethanolamine, of diethanolamine and of triethanolamine, of monoisopropanolamine, of diisopropanolamine or of triisopropanolamine, the salts of 2-amino-2-methyl-1-propanol , 2-amino-2-methyl-1,3-propanediol salts and tris(hydroxymethyl)aminomethane salts. Salts of alkali or alkaline-earth metals and in particular sodium or magnesium salts are preferably used.

Preferably, said anionic surfactants are chosen, alone or as a mixture, from:

- acyllactylates, in particular C12-C28 or even C14-C24, such as behenoyllactylates, and in particular sodium behenoyllactylate;

- C6-C24 and in particular C12-C20 N-acyltaurates;

- (C6-C24) alkyl ether carboxylates and in particular (C12-C20) alkyl ether carboxylate;

- C6-C24 and in particular C12-C20 alkylsulfosuccinates, in particular laurylsulfosuccinates, in particular sodium;

- C6-C24 and in particular C12-C20 alkylethersulfosuccinates, in particular laurylsulfosuccinates, oxyethylenated, in particular with 3 EO, in particular sodium;

- acylisethionates (C6-C24), preferably acylisethionates (C12-C18), and most particularly cocoylisethionates, in particular sodium;

- C6-C24 and in particular C12-C20 alkylsulfoacetates;

in particular in the form of alkali or alkaline-earth metal, ammonium or aminoalcohol salts.

In one embodiment, the anionic surfactant is chosen from C6-C24 and in particular C12-C20 alkyl ether sulfosuccinates, in particular lauryl sulfosuccinates, which are oxyethylenated, in particular with 3 EO, in particular sodium, preferably disodium laureth sulfosuccinate, sold under the name TEXAPON SB 3 UNKONS from BASF.

Advantageously, the anionic surfactant when it is present in the composition represents a content by weight ranging from 0.01% by weight to 10% by weight, preferably from 0.1% by weight to 5% by weight, more preferably from 0.1% by weight to 2% by weight, relative to the total weight of the composition.

Amphoteric or zwitterionic surfactant

The amphoteric or zwitterionic surfactants can be, for example, amino derivatives such as secondary or tertiary aliphatic amines, and optionally quaternized amino derivatives, in which the aliphatic radical is a linear or branched chain comprising 8 to 22 carbon atoms and containing at least a water-solubilizing anionic group (eg, carboxylate, sulfonate, sulfate, phosphate, or phosphonate).

The amphoteric surfactant can preferably be chosen from the group consisting of betaines and amidoaminecarboxylated derivatives.

It is preferable for the amphoteric surfactant to be chosen from surfactants of betaine type.

The betaine-type amphoteric surfactant is preferably chosen from the group consisting of alkylbetaines, alkylamidoalkylbetaines, sulfobetaines, phosphobetaines and alkylamidoalkylsulfobetaines, in particular (C8-C24) alkylbetaines, (C8-C24) alkylamido (C1- C8) alkylbetaines, sulfobetaines, and (C8-C24) alkylamido (C1-C8) alkylsulfobetaines. In one embodiment, the betaine-type amphoteric surfactants are chosen from (C8-C24) alkylbetaines, (C8-C24) alkylamido (C1-C8) alkylsulfobetaines, sulfobetaines and phosphobetaines.

Non-limiting examples include compounds classified in the CTFA International Cosmetic Ingredient Dictionary & Handbook, 15th Edition, 2014, as cocobetaine, laurylbetaine, cetylbetaine, coco/oleamidopropylbetaine, cocamidopropylbetaine, palmitamidopropylbetaine, stearamidopropylbetaine, cocamidopropylbetaine, palmitamidopropylbetaine, stearamidopropylbetaine, cocamidopropylbetaine, cocamidopropylhydroxysultaine, oleamidopropylhydroxysultaine, cocohydroxysultaine, laurylhydroxysultaine and cocosultaine, alone or in mixtures.

The betaine-type amphoteric surfactant is preferably an alkylbetaine and an alkylamidoalkylbetaine, in particular cocobetaine and cocamidopropylbetaine.

Among the amidoaminecarboxylated derivatives, mention may be made of the products marketed under the name Miranol, as described in U.S. Patent Nos. 2,528,378 and 2,781,354 and classified in the CTFA dictionary, 3rd edition, 1982 (the disclosures of which are incorporated herein by reference), under the names Amphocarboxyglycinates and Amphocarboxypropionates, with the respective structures:

R1-CONHCH2CH2-N+(R2)(R3)(CH2COO-)M+X-(B1)

in which:

R1 denotes an alkyl radical of an R1-COOH acid present in hydrolyzed coconut oil, a heptyl, nonyl or undecyl radical,

R2 denotes a beta-hydroxyethyl group,

R3 denotes a carboxymethyl group,

M ⁺ denotes a cationic ion derived from alkali metals such as sodium; ammonium ion; or an ion derived from an organic amine;

X ^- denotes an organic or inorganic anionic ion such as halides, acetates, phosphates, nitrates, alkyl (C1-C4) sulphates, alkyl (C1-C4) - or alkyl (C1-C4) aryl-sulphonates, in particular methyl sulphate and ethyl sulphate ; or M ⁺ and X ^- are not present;

R1'-CONHCH2CH2-N (B) (C) (B2)

in which:

R1' denotes an alkyl radical of an R1'-COOH acid present in coconut oil or in hydrolyzed linseed oil, an alkyl radical, such as a C7, C9, C11 or C13 alkyl radical, a C17 alkyl radical and its iso form, or an unsaturated C17 radical,

B represents -CH2CH2OX',

C represents - (CH2)z-Y', with z = 1 or 2,

X' denotes a group -CH2-COOH, -CH2-COOZ’, -CH2CH2-COOH, -CH2CH2-COOZ’, or a hydrogen atom, and

Y' denotes the radical -COOH, -COOZ', -CH2-CHOH-SO3Z', -CH2-CHOH-SO3H, or a radical -CH2-CH (OH) -SO3-Z’,

wherein Z' represents an ion of an alkali or alkaline earth metal such as sodium, an ion derived from an organic amine or an ammonium ion;

And

Ra’’ - NH-CH (Y’’) - (CH2) n-C (O) -NH- (CH2) n’-N (Rd) (Re) (B’2)

in which:

Y'' denotes -C(O)OH, -C(O)OZ'', -CH2-CH(OH)-SO3H or -CH2-CH(OH)-SO3-Z'', where Z'' denotes a a cationic ion derived from alkali or alkaline earth metals such as sodium, an ion derived from an organic amine or an ammonium ion;

Rd and Re denote a C1-C4 alkyl or C1-C4 hydroxyalkyl radical;

Ra’’ denotes a C10-C30g alkyl or alkenyl group, and

n and n' independently denote an integer from 1 to 3.

It is preferable for the amphoteric surfactant of formula B1 and B2 to be chosen from C8-C24 alkyl amphomonoacetates, C8-C24 alkyl amphodiacetates, C8-C24 alkyl amphomonopropionates and alkyl amphodipropionates. in C8-C24.

These compounds are classified in the CTFA dictionary, 5th edition, 1993, under the names Disodium Cocoamphodiacetate, Disodium Lauroamphodiacetate, Disodium Caprylamphodiacetate, Disodium Capryloamphodiacetate, Disodium Cocoamphodipropionate, Disodium Lauroamphopropionate, Disodium Caprylamphodiacetate, Disodium Caprylamphodiacetate, Disodium Cocoamphodipropionate, Disodium Lauroamphopropionate, Disodium Caprylamphopropionate.

By way of example, mention may be made of the cocoamphodiacetate marketed under the trade name Miranol® C2M concentrate by the company Rhodia Chimie.

Among the compounds of formula (B′2), mention may be made of sodium diethylaminopropyl cocoaspartamide (CTFA) marketed by CHIMEX under the name CHIMEXANE HB.

Advantageously, the amphoteric surfactant, when it is present in the composition according to the present invention, represents a content ranging from 0.01% by weight to 10% by weight, preferably from 0.1% by weight to 5% by weight, more preferably from 0.1% by weight to 2% by weight, relative to the total weight of the composition.

The preferred surfactant(s), which can be used in the deodorant micellar water of the present invention, are chosen in particular from amphoteric, nonionic or anionic and/or zwitterionic surfactants, listed below:

As amphoteric or zwitterionic surfactant , mention may be made of:

alkyl betaines, such as cocoyl betaine (or coco betaine), lauryl betaine;

alkylamphoacetates such as N-cocoyl-N-carboxymethoxyethyl-N-carboxymethyl-ethylenediamine N-di-sodium (CTFA name: Disodium cocoampho-diacetate) marketed in aqueous saline solution under the name MIRANOL C2M CONC NP by the company Rhodia Chimie; N-cocoyl-N-hydroxyethyl-N-carboxymethyl-ethylenediamine N-sodium (CTFA name: sodium cocampho-acetate);

cocamides such as the mixture of ethanolamides of coconut acid (CTFA name: Cocamide DEA);

and their mixtures.

As nonionic surfactant , mention may be made in particular of:

fatty acid and polyol esters, and in particular glyceryl and fatty acid esters, such as the PEG-6 fatty acid ester Caprylic/capric glycerides by the company SASOL under the name SOFTIGEN 767;

polycondensates, in particular polymers with oxyethylenated oxypropylene blocks such as Poloxamers and in particular Poloxamer 184 (CTFA name);

sorbitan fatty acid esters and their oxyethylenated derivatives, such as sorbitan monostearate (CTFA name: Sorbitan stearate) sold by the company ICI under the name Span 60, sorbitan monopalmitate (CTFA name: Sorbitan palmitate) sold by the company ICI under the name Span 40, the oxyethylenated sorbitan stearates, palmitates and oleates (CTFA name: Polysorbate) sold by the company ICI under the names Tween, in particular Polysorbate 60 (Tween 60), Polysorbate 65 (Tween 65), Polysorbate 80 (Tween 80);

oxyethylene ethers of dihydrocholesterol, such as Dihydrocholeth-15, Dihydrocholeth-20, Dihydrocholeth-30;

alkylpolyglycosides and in particular alkylpolyglucosides (APG) having an alkyl group containing from 6 to 30 carbon atoms (alkyl-C6-C30 polyglucosides) and preferably 8 to 16 carbon atoms, such as for example decylglucoside (Alkyl-C9/C11 -polyglucoside), such as the product marketed under the name MYDOL 10 by the company Kao Chemicals, the product marketed under the name PLANTAREN 2000 UP or PLANTACARE 2000 UP by the company Cognis, and the product marketed under the name ORAMIX NS 10 by the Seppic; caprylyl/capryl glucoside, such as the product marketed under the name ORAMIX CG 110 by the company Seppic; laurylglucoside, such as the products marketed under the names PLANTAREN 1200 N and PLANTACARE 1200 by the company Cognis; and coco-glucoside, such as the product marketed under the name PLANTACARE 818/UP by the company Cognis;

and their mixtures.

As anionic surfactant , mention may be made in particular of:

alkyl sulfates and their salts;

alkyl ether sulfates and their salts, in particular their sodium salts, such as sodium trideceth sulfate, the mixture of Sodium Laureth Sulfate / Magnesium Laureth Sulfate / Sodium Laureth-8 Sulfate / Magnesium Laureth-8 Sulfate, sold under the name of Texapon ASV by Cognis; sodium lauryl ether sulphate (C12-14 70/30) (2.2 EO) marketed under the names SIPON AOS 225 or Texapon N702 PATE by the company Cognis; ammonium lauryl ether sulphate (C12-14 70/30) (3 EO) marketed under the name SIPON LEA 370 by the company Cognis; ammonium (C12-C14) alkyl ether (9 EO) sulphate marketed under the name RHODAPEX AB/20 by the company Rhodia Chimie;

alkyl phosphates;

and their mixtures.

In particular the following 4 combinations are preferred:

• Antiperspirant + polycondensate, such as poloxamer: this preferred combination has the advantage of being less sticky than an Antiperspirant + PEG surfactant combination.

In the formulas exemplified below, the surfactant contents have been optimized to obtain the least sticky micellar water possible while having micelles, and in particular a detectable micellarity.

The following 3 combinations use surfactants of natural origin, and are part of also preferred alternative embodiments of the invention:

• Antiperspirant + sodium cocoate

• Antiperspirant + cocobetaine

• Antiperspirant + disodium cocoamphodiacetate

According to a very particularly preferred embodiment, the micellar water according to the invention advantageously comprises at least one polycondensate of ethylene oxide and propylene oxide, and more particularly a copolymer consisting of polyethylene glycol and polypropylene glycol blocks. , such as, for example, the polyethylene glycol/polypropylene glycol/polyethylene glycol triblock polycondensates. These triblock polycondensates have, for example, the following chemical structure:

H-(O-CH2-CH2)a-(O-CH(CH3)-CH2)b-(O-CH2-CH2)a-OH,

formula in which a ranges from 2 to 150, and b ranges from 1 to 100; preferably a ranges from 10 to 130 and b ranges from 20 to 80.

The polycondensate of ethylene oxide and propylene oxide preferably has a weight-average molecular weight ranging from 1000 to 15000, and better ranging from 1500 to 15000, and in particular ranging from 1500 to 10000, and even better ranging from 1500 to 5000.

Advantageously, said polycondensate of ethylene oxide and propylene oxide has a cloudy temperature, at 10 g/l in distilled water, greater than or equal to 20°C, preferably greater than or equal to 60°C. Cloud temperature is measured according to ISO 1065.

As polycondensate of ethylene oxide and propylene oxide which can be used according to the invention, mention may be made of the triblock polyethylene glycol/polypropylene glycol/polyethylene glycol polycondensates sold under the names "SYNPERONIC" such as "SYNPERONIC® PE/F32". (INCI name: POLOXAMER 108), “SYNPERONIC® PE/F108” (INCI name: POLOXAMER 338), “SYNPERONIC® PE/L44” (INCI name: POLOXAMER 124), “SYNPERONIC® PE/L42 (INCI name: POLOXAMER 122 ), "SYNPERONIC® PE/F127" (INCI name: POLOXAMER 407), "SYNPERONIC® PE/F88" (INCI name: POLOXAMER 238), "SYNPERONIC® PE/L 62" (INCI name: POLOXAMER 182), "SYNPERONIC ® PE/L64” (INCI name: POLOXAMER 184) by the company CRODA, or even “LUTROL® F68” (INCI name: POLOXAMER 188) by the company BASF.

The polycondensate of ethylene oxide and propylene oxide may be present in the composition according to the invention in a content ranging from 0.01% to 5% by weight, relative to the total weight of the composition, preferably ranging from 0.05% to 2% by weight, preferably ranging from 0.05% to 1% by weight and even better from 0.07% to 0.5% by weight.

According to an advantageous embodiment of the invention, the surfactants used in the micellar water according to the invention are very particularly chosen from the following surfactants, indicated by INCI name, which have the additional particularity of exhibiting an antimicrobial activity of interest for the deodorant application targeted by the present invention: Sodium Laureth Sulfate, alkylpolyglucoside, lauryl ether carboxylic acid, polymer with polyoxyethylene blocks and polyoxypropylene blocks, such as poloxamer 184, sodium surfactin which is a lipopeptide composed of amino acids and fatty acids and is produced by the fermentation of Bacillus subtilis (INCI name Surfactin Sodium Salt), Cocobetaine, (Cocamidopropyl betaine), COCAMIDE MIPA (COPRAH ACID MONOISOPROPANOLAMIDE), CETYL TRIMETHYL AMMONIUM CHLORIDE, COCO GLUCOSIDE, LAURETH-4, LAURETH-12, Laureth-5 carboxylic, Laury ether sulfate 2 OE, Disodium laureth sulfosuccinate, Olefin sulfonate, Lauryl sulfa Ammonium Te, Sodium Lauryl Sulfate, Sodium Lauroyl Sarcosinate, Sodium Methyl Isethionate, Rhamnolipid, Lauric Acid, Sodium Lauroyl Lactylate, Cocobetaine, SODIUM (C14-16) OLEFIN SULFONATE, ALKYL (C8/C10/C12/C14 34/24 /29/10) POLYGLUCOSIDE (1,4), LAURIC ALCOHOL OXYETHYLENE (4 EO), LAURYL ETHER CARBOXYLIC ACID (4.5 EO), ALKYL (C8/C10 50/50) POLYGLUCOSIDE (2), LAURIC ALCOHOL OXYETHYLENE (12 EO) , 1-HYDROXY-4-METHYL 6-TRIMETHYLPENTYL 2-PYRIDONE, MONOETHANOLAMINE SALT

SODIUM LAUROYL METHYL ISETHIONATE, ALKYL (C8/C16) POLYGLUCOSIDE (1.4), SODIUM (C14-16) OLEFIN SULFONATE ALKYL (C8/C10/C12/C14 34/24/29/10) POLYGLUCOSIDE, LAURIC ALCOHOL OXYETHYLENE (4 EO) , ALKYL (C8/C10 50/50) POLYGLUCOSIDE (2); and mixtures of these surfactants.

Electrolytes

The aqueous composition can also include electrolytes. These electrolytes can be chosen from monopotassium or dipotassium phosphate, sodium chloride, magnesium sulphate.

The electrolytes may be present in an amount of between 0.1 and 5%, preferably between 0.5 and 2% by weight relative to the total weight of aqueous composition.

Additives

The composition according to the invention may also comprise one or more additional compounds chosen from perfumes, peptizing agents (approximately 1%), vitamins and preservatives, or any other ingredient usually used in cosmetics for this type of application.

The composition according to the present invention may comprise any one of the following additives: sequestrants, antioxidants; biological extracts (eg RIBES NIGRUM (BLACK CURRANT) BUD EXTRACT); antibacterial agents, fragrances (eg perfumes, essential oils), thickeners (eg glycol distearate) and cationic preservatives (eg myrtrimonium bromide).

A person skilled in the art can adjust the type and amount of additives present in the compositions according to the present invention by means of routine operations, so that the desired properties of these compositions, in particular transparency, are not adversely affected by these additional compounds.

Galenic

The micellar composition according to the invention is liquid.

By “liquid”, it is meant that the composition is sufficiently fluid to be stirred and/or to be able to be sprayed. The micellar composition according to the invention is thus not solid, and in particular is neither a stick nor a roll-on.

Within the meaning of the present invention, the term “micellar water” in fact means a composition having a texture very similar to water, more precisely, the composition has a viscosity very close to that of water.

More particularly, the viscosity of the micellar water defined in the present invention is less than or equal to 500 mPa.s, preferably less than 200 mPa.s, more preferably less than 100 mPa.s, and even more preferably less than 50 mPa.s, or even less than 20 mPa.s, or better still less than 10 mPa.s. For example, the micellar water of the present invention has a viscosity of 1.2 mPa.s.

The micellar composition of the invention is preferably a transparent liquid which appears clear, colorless and transparent like water to simulate the physical appearance of water.

The word "transparent" within the meaning of the present invention means that the composition has a turbidity of less than or equal to 300 NTU. The transparency of a composition can be measured by its turbidity, and NTUs (Nephelometric Turbidity Units) are the units of measurement of the turbidity of a composition. The turbidity measurement can be made for example with a model 2100P turbidimeter from HACH Company, the tubes used for the measurement being referenced AR397A cat 24347-06. The measurements are carried out at room temperature (20°C to 25°C). The two distinct phases of the composition in accordance with the invention have a turbidity generally ranging from 0.1 to 300 NTU, and preferably from 1 to 100 NTU.

The micellar composition according to the invention may be contained in a device allowing its application, in particular by spraying, to the skin. Preferably, this device is a pump bottle, or bottle equipped with a spray device or spray, or compressed gas (air or N2) aerosol bottle.

A subject of the present invention is therefore also a device comprising the micellar composition according to the invention, said device preferably being a pump bottle, in particular made of plastic (of the PET type) or of glass, the bottle itself preferably being transparent, in particular to reveal the transparent antiperspirant micellar water according to the invention.

Process

The present invention also relates to a cosmetic process for the treatment and/or care of human keratin materials, preferably the skin, comprising the agitation of a micellar composition according to the invention, then its application to the surface of said keratin materials. Agitation is typically done manually.

The present invention also relates to a cosmetic process for treating human perspiration and/or body odor linked to perspiration, consisting in agitating a micellar composition according to the invention, then in applying it to the surface of a human keratin material.

Examples

The examples which follow make it possible to better understand the invention without however presenting a limiting character.

The compositions in the tables below were prepared and then applied and evaluated according to the protocols listed and described below.

The formulas were evaluated and sprayed using a compressed air aerosol dispensing device with the following characteristics: Aptar 2x05/1.6 valve and Aptar DU 2520 nozzle.

The sticky power

The purpose of this characterization test is to define the stickiness of aerosol formulas at T=0min, T=5min and T=10min.

The method consists of depositing a sprayed product of 0.15g on “supplale” which is a specific medium that makes it possible to mimic human skin and thus get closer to vivo. The supplale is placed on a hot plate at 35°C. The sprayed mass of 0.15g corresponds to the average quantity deposited in one second by an aerosol. Subsequently, the support containing the product is placed on sand with a defined weight of 250g applied to it for 5 seconds. The support with the product and the sand are stirred three times and weighed. The mass of sand remaining on the supple after shaking makes it possible to determine the tackiness of the formula tested.

The wetting power

The purpose of the evaluation is to characterize the wetting effect of aerosol formulations. This test was carried out at two times, T=0min and T=2min.

The protocol consists in depositing via the aerosol an exact and known mass of product of 0.66 g on supple at 35°C. The mass of product deposited corresponds to the quantity of product applied by a consumer to a surface of 100 cm ² . Then, an absorbent paper and a weight of 50 g are applied to the deposit for 5 seconds. The mass of product present on the paper allows us to know the quantity of product transferred.

The spray angle

The purpose of the evaluation is to characterize the vaporization angle obtained at the aerosol outlet.

On leaving the aerosol, it is assessed whether the spray angle is in the form of a unidirectional jet, whether there is clogging or whether the spray angle forms burst droplets equivalent to conventional antiperspirants.

Diffusion test

Goal: Determine the angle of impact of the spray and the ability of the product to diffuse

Method: Make a deposit on a support to be defined and measure the diffusion diameter of the product.

Materials:

Supports: tracing paper, cardboard, blotter

Drying test / BYK Altana Device

Supports: blade, sparadra

Nature of deposit: spray

A hydrophilic dye (INCI name: ACID BLACK 1) is used to mark the product tested.

Purpose: To determine the drying time of the product.

Method: Spread the product on a glass slide using a spreading bench then mark the film using needles in order to observe the drying time at the moment when a groove appears on the dry deposit.

Drying test / Image Device J

Purpose: To observe the time required for the product to dry.

Method: Homogeneous deposit on plastic plate. Then, place strips of absorbent paper for 5 seconds at different times. After the 5 sec quantify the presence of product on the absorbent strip (Imagej).

Materials:

Non-absorbent support (plastic plate with or without plaster)

Absorbent support: special paper.

Dye

Protocol:

Deposition of the product by spray (start of the stopwatch).

Place a strip of paper at different times:

0sec / 1min / 2min / 3min / 4min / 5min / 6min / 7min / 8min

Apply a weight of 155 g to the paper for 5 seconds.

Additional drying test

Purpose: To observe the time required for the product to dry.

Method: make a homogeneous deposit on bio-skin. The bio-skin is deposited on the heating plate. At different times, the mass of the support is weighed with the product.

Materials:

Bio-skin support

Hotplate

Precision scale.

Behavior test of the sprayed deposit during drying

Purpose: To observe the drying time of the deposit and its rigidity.

Method: observe the rigidity of the deposit (flexible/rigid) during the formation of the film (friable/grip) during drying on bio-skin on a hot plate (at 37°C).

Materials:

Support types: bio-skin.

Heating the plate to 37°C

Observation of drying at different times

Visual characterization of the behavior of the deposit: flexible, rigid, friable, grip.

Standard spraying for a spray time of 1 sec/3 sec/5 sec according to the criterion observed:

Protocol:

Support 1: bio - rectangular skin:

Spray time 1 sec => determine the drying time

Spray time 5 sec => assess diffusion and flow

Support 2: bio – circular skin:

Spray time 3 sec => film formation +/- flexible

Observation time: 12 hours / 24 hours / 48 hours

Absorption test

Purpose: To observe the ability of the product to be absorbed.

Method: Make a spray deposit on a support that does not absorb (blade or stainless steel). Then superimpose on this same deposit a support which absorbs (fabric) in order to read the transfer of the deposit on the absorbent support.

Material :

Supports: blade, stainless steel, paper or fabric

Heating plate, heated to 37°C (body temperature)

155g weight

Different times to mimic drying before getting dressed.

Adhesion test

Purpose: To observe the ability of the product to cling to the support.

Method: The skin is placed on a support, perpendicular to the table top.

Method: Perform a spray on a support that mimics the skin. Observe whether or not the product deposit clings to the support and note its flow.

Protocol: Place the bio-skin on the vertical metal support 15 cm from the spray area.

Place the aerosol in its location and apply a simple pressure.

Start the stopwatch when the spray starts.

We compare the grip of the compositions BSC + ACH, BSC, Water +ACH

Wear test / tribology

Aim: To observe the resistance of the product following the force exerted by the rotation of a ball.

Method: Deposit the product on a well 100 µm deep. Start the rotation of the ball on the deposit and observe the resistance of the product.

Carry out 6 tests per formulation.

Materials:

Support types: steel cup, bio-skin.

CSM Disc Pawn Tribometer

Deposit depth: 45 µm

A hydrophilic dye (INCI name: ACID BLACK 1) is used.

Glove box test

Purpose: To measure the resistance of the product in the presence of humidity or sweat.

Method: Make a deposit on a support that mimics the skin (bio-skin) and set the glove box to 80% relative humidity at 37°C. Then observe if the product comes off the support and evaluate the time required for this action.

Materials: Bio-skin support, glove box at 80% relative humidity, at a temperature of 37°C.

Rheological study -Viscosity test

compressed air aerosol dispensing device with the following characteristics: Aptar 2x05/1.6 valve and Aptar DU 2520 nozzle

The study of spraying several formulas of different viscosities has shown that for a formula to be propellable in a multidirectional spray (with the device selected above) it is imperative to be in the following rheological conditions:

Viscosity at 1000 s −1 <0.048 Pa.s, which is verified for all the compositions tested in the examples below.

Stability :

The evaluation of the stability of the formula is carried out on the "juice" and not at the aerosol outlet. This product evaluation criterion is determined by an accelerated aging program. A quantity of 60 g of formula in a 100 ml glass pillbox is placed for 15 days at room temperature (25°C) and in an oven at 45°C. By “stable” product, we mean, within the meaning of the invention, a product which does not phase out, or does not sediment after at least 15 days at 25°C and at 45°C.

Influence of micellarity on the drying of the sprayed aqueous composition :

micellarity test - CMC determination :

Protocol:

- Volumetric dosing coupled with a conductivity meter

- Beaker containing all the MPs except the surfactants (TA)

- Introduction of TA mixture

- Evaluation of the volume of AT introduced (in ml), for the maximum conductivity (mS/cm) obtained on the conductivity measurement curve as a function of the volume (ml) of TA introduced.

The volume of the TA mixture introduced (here 0.255 ml) to achieve micellarity, corresponding to a total content by weight of 0.65% by weight of surfactant mixture, on the total weight of the composition below according to Table 1 .

4 aqueous antiperspirant compositions are prepared comprising water and aluminum hydroxychloride (ALUMINUM CHLOROHYDRATE abbreviated ACH) as antiperspirant agent, with the following respective contents of mixture of surfactants:

• 0% TA,
• 0.25% of TA so we place ourselves before the CMC,
• 0.65% of TA so we are at the CMC
• 7% TA so we are beyond the CMC so the composition of Ex1 is micellar, it is a micellar water according to the invention.

US INCI Cp1
Comparative Cp2
Invention Cp3
Invention Ex 1
Invention 0% TA TA < CMC
0.25% TA = CMC
0.65% TA >> CMC
7% WATER 92.50 78.23 78.23 78.23 ALUMINUM CHLOROHYDRATE 7.50 7.50 7.50 7.50 MYRTRIMONIUM BROMIDE 0.07 0.07 0.07 GLYCERIN 5.00 5.00 5.00 PEG-7 CAPRYLIC/CAPRIC GLYCERIDES 0.07 0.19 2.00 PEG-6 CAPRYLIC/CAPRIC GLYCERIDES 0.04 0.09 1.00 POLOXAMER 124 0.07 0.19 2.00 POLOXAMER 184 0.07 0.19 2.00 POLYSORBATE 80 1.00 1.00 1.00 DISODIUM EDTA 0.20 0.20 0.20 FRAGRANCE 1.00 1.00 1.00 Drying time (mins) (BYK ALTANA) 40 30 25 20 Quantity (%) of product at time
t = 20 mins ( PICTURE j) 65 25 20 10 Drying behavior Rigid deposit Soft deposit Soft deposit Very flexible deposit Gripping power ( in dry waves ) 1 30 100 110

Conclusion :

After spraying and evaluations carried out according to the protocols described above, we can conclude that:

The antiperspirant micellar water of the invention has a much shorter drying time than compositions which are not micellar.

At body temperature, micellar water forms a very flexible film on the support, while antiperspirant water without any surfactant forms a rigid deposit.

Micellar water has a better gripping power compared to antiperspirant water which is not micellar.

It appears from the above results that the speed of drying, the flexibility of the film deposited and the adhesion power of the formula are significantly improved by the presence of micelles in the aqueous micellar antiperspirant composition according to the present invention. .

US INCI Ex 1 Ex 2 Ex 5 Ex 3 Ex 4 WATER 78.23 86.53 88.53 88.53 87.78 ALUMINUM CHLOROHYDRATE 7.50 7.50 7.50 7.50 7.50 MYRTRIMONIUM BROMIDE 0.07 0.07 0.07 0.07 0.07 GLYCERIN 5.00 PEG-7 CAPRYLIC/CAPRIC GLYCERIDES 2.00 PEG-6 CAPRYLIC/CAPRIC GLYCERIDES 1.00 POLOXAMER 124 2.00 2.00 0.75 0.75 0.75 POLOXAMER 184 2.00 2.00 0.75 POLOXAMER 182 0.75 0.75 POLYSORBATE 80 1.00 DISODIUM EDTA 0.20 PPG-26-BUTETH-26 0.54 0.54 0.54 0.54 PEG-40 HYDROGENATED CASTOR OIL 0.36 0.36 0.36 0.36 STEARETH-100/PEG-136/HDI COPOLYMER 0.5 0.50 1.25 FRAGRANCE 1.00 1.00 1.00 1.00 1.00

The formula of Example 3 was subjected to a sensory evaluation test on a panel of 129 people, the results of which are shown below.

The formulas of examples 1 to 5 are examples of transparent micellar waters according to the invention.

Ex6 Cp7 Cp8 Ex9 US INCI decrease in poloxamer surfactants TEST
WITHOUT TA
WATER + ACH WATER MICELLE TEST + TA WATER MICELLE TEST + TA +ACH WATER 89.03 92.50 98.03 90.53 ALUMINUM CHLOROHYDRATE 7.50 7.50 7.50 PPG-26-BUTETH-26 0.54 0.54 0.54 STEARETH-100/PEG-136/HDI COPOLYMER 0.50 POLOXAMER 182 0.50 0.50 0.50 POLOXAMER 124 0.50 0.50 0.50 PEG-40 HYDROGENATED CASTOR OIL 0.36 0.36 0.36 MYRTRIMONIUM BROMIDE 0.07 0.07 0.07 FRAGRANCE 1.00

The formulas of examples Ex6 and Ex9 are examples of transparent micellar waters according to the invention.

Ex10 Ex11 Ex12 INCI substitution of poloxamers with other preferred TAs increased blood pressure peptizer increase WATER 89.46 89.27 89.01 ALUMINUM CHLOROHYDRATE 7.50 7.50 7.50 FRAGRANCE 1.00 1.00 1.00 PPG-26-BUTETH-26 0.54 0.54 0.81 STEARETH-100/PEG-136/HDI COPOLYMER 0.50 0.50 0.50 PEG-40 HYDROGENATED CASTOR OIL 0.36 0.36 0.54 SODIUM COCOAMPHOACETATE 0.24 0.32 0.24 COCO-BETAINE 0.23 0.30 0.23 SODIUM CHLORIDE 0.11 0.14 0.11 MYRTRIMONIUM BROMIDE 0.07 0.07 0.07 transparency OK OK OK micellarity OK OK OK

The compositions Ex10 to Ex12 according to the invention are all transparent and micellar. In Ex12, the increase in the peptizer allows, while optimizing the transparency of the micellar water, to help the solubilization of the perfume in the micellar water.

The turbidity and micellarity tests carried out on these compositions confirm that they are indeed both transparent and micellar within the meaning of the present invention.

On the other hand, the 2 surfactants used are particularly interesting: SODIUM COCOAMPHOACETATE and COCO-BETAINE are of renewable origin, their preparation process has a low environmental footprint (especially in water).

E valuation of the antiperspirant effect of the composition of the Ex 5 according to the invention

The objective was to evaluate the antiperspirant efficacy of the composition of Ex 5 compared to an untreated armpit, at 24 and 48 hours after 4 applications.

Randomized, comparative test (untreated armpit), single-blind.

Panel: 41 subjects (women); Age: between 20 and 55 years old (average: 40 years old)

Main inclusion criteria: subjects producing at least 100 milligrams of sweat/armpit/20 minutes collected during baseline session in warm room (80 minutes, 37.8 ± 1°C, 30-40% relative humidity) .

M method measuring gravimetric

Measurement time

● T0 (reference - before treatment)

● T24h (24 hours after four applications)

● T48h (48 hours after four applications)

Gravimetric method for measuring the AT effect before / after treatment

Zone: one randomized armpit

Pre-conditioning (washing period): 21 days

Application frequency: once a day

Application period: 4 days

Quantity: 0.4 g of the product is applied in a controlled and random manner by a qualified technician, to an area of 100 cm2 of the armpit.

After the baseline warm room session, subjects performed supervised washing of their armpits with standard liquid soap and received a controlled application of 0.4 g of the product at random by a trained technician. On the following two days (Saturday and Sunday), the subjects were asked to apply the product delivered by the study staff at home. Then the subjects returned to the research center for the 2nd controlled product application performed by a qualified technician. The amount of product was always 0.4 g determined by a calibrated pipette. Hot chambers (80 minutes, 37.8 ± 1°C, 30–40% relative humidity) were again performed to assess antiperspirant efficacy 24 and 48 hours after the fourth application of the product.

Statistical analysis

AT efficacy was assessed by determining the changes in ratio between sweat output from the treated armpit and sweat output from the untreated armpit for each volunteer.

Software used: IBM® SPSS® Statistics 20.0.

Results

Tables 5 and 6 summarize the results 24 and 48 hours after four applications.

Mean amounts of sweat 24 hours after fourth product application and difference from baseline, n=41.

PRODUCT T0
(reference)
Mean values (mg) ± 95% CI T24h
(24h after the 4th application)
Mean values (mg) ± 95% CI Average difference compared to the initial value
(mg) Average difference compared to the initial value
(%) Untreated armpit
(reference) 767.0±96.1 716.4±95.1 -50.6 -6.6 Ex 5
Product tested 814.3±125.2 584.4±92.9 -229.9 -28.2 Difference
Ex5 – untreated armpit -47.3 132 179.3 21.6

Mean amounts of sweat 48 hours after fourth product application and difference from baseline, n=41.

PRODUCT T0
(reference)
Mean values (mg) ± 95% CI T48h
(48h after the 4th application)
Mean values (mg) ± 95% CI Mean difference from baseline (mg) Mean difference from baseline (%) Untreated armpit
(reference) 767.0±96.1 772.1±94.9 5.1 0.7 Ex 5
Product tested 814.3±125.2 716.1±99.3 -98.2 -12.1 Difference
Ex5 – untreated armpit -47.3 56.0 103.3 12.7

These results show significant differences, in particular a marked reduction in perspiration between the untreated armpit and that treated with the product of Ex 5 according to the invention, 24 hours and 48 hours after 4 applications, in favor of the product tested ( Ex 5).

Sensory evaluation and performance tests perceived by users:

The formula of Example 3 (Ex 3) was evaluated.

LUD test, Monadic, 21-day trial of the product in a spray pump bottle, Country: France Target and sample size 129 women aged 18-55, aerosol users, mass market, including 80 users looking for more naturalness in the products used.

Overall satisfaction
% Satisfied 89% % dissatisfied 11% Performance vs usual antiperspirant
% best 77% % much better 52% % worse 14%

Sensoriality When applying the spray Pleasant spray The product is pleasant to use % Totally agree 93% % Completely agree 65% Somewhat agree 28% Neither agree nor disagree 6% % Totally Disagree 1% somewhat disagree 1% completely disagree 0% Soft spray Spray strength After applying the spray % Too strong 8% % AVERAGE 69% % Too weak 22%

Long-lasting dry feeling, clean and fresh effect:

At the end of the day Long-lasting efficiency (no humidity) % Totally agree 79% % Completely agree 46% % Totally Disagree 13% Long lasting fragrance % Totally agree 72% % Completely agree 41% % Totally Disagree 17% When applying Immediate signs of effectiveness and fresh effect % Totally agree 87% % Completely agree 57% % Totally Disagree 4% Immediate signs of efficacy and specific effect % Totally agree 90% % Completely agree 56% % Totally Disagree 2%

Perceived effectiveness:

At the end of the day Prevents bad odors = by masking, neutralizing % Totally agree 83% % Completely agree 56% % Totally Disagree 9% Antiperspirant effect % Totally agree 80% % Completely agree 52% % Totally Disagree 13% No visible sweat marks % Totally agree 80% % Completely agree 48% % Totally Disagree 9% When applying Fragrance transmitting clean effect % Totally agree 84% % Completely agree 59% % Totally Disagree 10%

Immediate feeling of dry, clean and fresh during application:

When applying Non-sticky on the armpits % Totally agree 79% % Completely agree 49% % Totally Disagree 15% Not sticky on clothes % Totally agree 86% % Completely agree 53% % Totally Disagree 9% Non-wet texture under the armpits % Totally agree 48% % Completely agree 21% % Totally Disagree 38% Non-wet texture on clothes % Totally agree 70% % Completely agree 48% % Totally Disagree 16%

Aesthetic skin finish Improves the appearance of the skin under the armpits % Totally agree 61% % Completely agree 31% % Totally Disagree 7% Drying time % Too fast 3% % AVERAGE 65% % Too slow 32% The appearance of the formula gives a clean perception % Totally agree 80% % Completely agree 44% % Totally Disagree 5% The appearance of the formula gives a perception of freshness % Totally agree 81% % Completely agree 44% % Totally Disagree 5%

Comparison of the composition of the Ex 3 against 2 benchmarks (Dove original and Dove vapopump), also evaluated by the LUD test. The contents by weight (of active ingredient) of aluminum salts are given in Table 13.

Original Dove Compressed Dove original PUMP AP Pump Spray Figure 1 Figure 2 Figure 3 10%ACH 12%ACH 7.5%ACH BENCHMARK BENCHMARK PROTOTYPE Ex3

Original Dove Dove vapopump Ex3 Vapopump Acceptable trace level No residue on the skin (white marks) % Totally agree 90% 93% 95% % Completely agree 71% 75% 69% % Totally Disagree 7% 4% 3% No transfer on clothes % Totally agree 93% 92% 93% % Completely agree 64% 69% 58% % Totally Disagree 3% 3% 1% Easy to use Easy to use % Totally agree 100% 95% 95% % Completely agree 81% 70% 63% % Totally Disagree 0% 1% 1% Precise application % Totally agree 93% 86% 77% % Completely agree 65% 48% 43% % Totally Disagree 2% 10% 15% No product wastage % Totally agree 86% 84% 88% % Completely agree 67% 56% 61% % Totally Disagree 8% 7% 8% The spray has clogged exact 6% 7% 5% no he never was 94% 93% 95%

Original Dove Dove vapopump Ex3 Vapopump Original and unique character
Compared to other antiperspirants, would you say this antiperspirant is… Extremely differ 32% 47% 50% rather different 53% 48% 48% no different 15% 5% 2% naturalness
More eco-friendly 39% 59% 69% Also eco-friendly 53% 37% 31% Less eco-friendly 8% 4% 1%

Claims (16)

Aqueous transparent antiperspirant and/or deodorant micellar composition comprising:
- some water
- at least one antiperspirant and/or deodorant active ingredient; And
- at least one surfactant. Composition according to Claim 1, characterized in that it is in the form of a transparent and colorless micellar water, preferably having the same appearance as water, and in particular the same texture as liquid water under the conditions ambient temperature (25°C) and pressure (100 kPa). Composition according to any one of the preceding claims, characterized in that it contains free micelles, detectable in particular by "dynamic light scattering" DLS spectroscopic analysis based on the principle of dynamic light scattering, said micelles preferably having a diameter median D50 included in the range of 10 to 50 nm. 4. Composition according to any one of the preceding claims, characterized in that the content by weight of said at least one surfactant in the composition corresponds to a concentration of said at least one surfactant in the composition greater than the critical micellar concentration (CMC) of said at least one surfactant in the composition, said CMC being determined by tensiometry. 5. Composition according to any one of the preceding claims, characterized in that the content of fatty substances, in particular fatty substances that are liquid at room temperature (25° C.), such as oil, if the composition contains it, does not does not exceed 2% by weight, preferably does not exceed 1% by weight, preferably does not exceed 0.5% by weight, preferably does not exceed 0.2% by weight, on the total weight of the composition, of preferably, the composition being devoid of, or even completely free of, fatty substances, in particular liquids, such as oil. 6. Composition according to any one of the preceding claims, characterized in that the antiperspirant active ingredient is chosen from antiperspirant salts or complexes of aluminum and/or zirconium, preferably from aluminum halohydrates; aluminum and zirconium halohydrates, zirconium hydroxychloride and aluminum hydroxychloride complexes with or without an amino acid, aluminum chlorohydrex, aluminum chlorohydrex, aluminum chlorohydrex polyethylene glycol complex, aluminum complex chlorohydrex propylene glycol, aluminum dichlorohydrate, aluminum dichlorohydrex polyethylene glycol complex, aluminum dichlorohydrex propylene glycol complex, aluminum sesquichlorohydrate, aluminum sesquichlorohydrex polyethylene glycol complex, aluminum sesquichlorohydrex propylene glycol complex, aluminum sulfate buffered with sodium lactate and d aluminum, aluminum zirconium octachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine and aluminum zirconium trichlorohydrex glycine, and mixtures thereof. 7. Composition according to any one of the preceding claims, characterized in that the antiperspirant active ingredient is present in the composition in the proportion of 1 to 40% by weight, preferably from 1 to 30% by weight, preferably from 5 to 25% by weight, preferably from 5 to 20% by weight, preferably from 7 to 15% by weight of active material relative to the total weight of the composition. 8. Composition according to any one of the preceding claims, characterized in that the deodorant active ingredient is chosen from:
- antibacterial, bacteriostatic or bactericidal agents, such as:
2,4,4'-trichloro-2'-hydroxydiphenyl ether (Triclosan),
2,4-dichloro-2'-hydroxydiphenyl ether,
3',4',5'-trichlorosalicylanilide,
1-(-3',4'-dichlorophenyl)-3-(4'chlorophenyl)urea (Triclocarban)
or 3,7,11-trimethyldodeca-2,5,10-trienol (Farnesol);
quaternary ammonium salts such as cetyltrimethylammonium salts, cetylpyridinium salts;
chlorhexidine and salts;
polyhexamethylene biguanide salts;
salicylic acid, its salts and its derivatives;
triethylcitrate, biguanide, polylysine, caprylhydroxamic acid, ethylzingerone, tromethamine;
palmitoyl lisine histidine/proline/arginine NH2 acetate salts,
ethyl lauroyl arginate hydrochloride;
- alcohols, such as caprylyl glycol, polyhydroxyamines (aminopropanediols), ethyl hexyl glycerin, ethanol, 2-methyl 5-cyclohexylpentanol, 4-(1-phenylethyl)-1,3-benzenediol;
- zinc salts such as zinc salicylate, zinc phenolsulfonate, zinc pyrrolidone carboxylate (more commonly known as zinc pidolate), zinc sulfate, zinc chloride, zinc lactate, zinc gluconate, zinc ricinoleate, zinc glycinate, zinc carbonate, zinc citrate, zinc chloride, zinc laurate, zinc oleate, zinc orthophosphate, zinc stearate, zinc tartrate zinc, zinc lactate, zinc acetate or mixtures thereof;
- polymers such as polyvinylamine, polyethyleneimine, lauryl methacrylate/glycol dimethacrylate copolymer;
- other inorganic salts, such as sodium hydrogen carbonate NaHCO3, calcium hydroxide Ca(OH)2;
- odor absorbers such as zeolites, cyclodextrins, metal oxide silicates; derivatives of chitosan;
- substances blocking the enzymatic reactions responsible for the formation of odorous compounds such as triethyl citrate, arylsulfatase, 5-Lipoxygenase, aminocyclase and β-glucoronidase inhibitors;
- essential oils, in particular deodorants,
- extracts, such as usnea barbata extract
- and mixtures thereof. 9. Composition according to any one of the preceding claims, characterized in that the said at least one deodorant active ingredient is present in the aqueous composition in a content of 1 to 30% by weight of active ingredient relative to the total weight of aqueous composition, and preferably from 1 to 20%, preferably from 1 to 10% by weight of active material on the total weight of the composition. 10. Composition according to any one of the preceding claims, characterized in that the said at least one surfactant is chosen from amphoteric, nonionic or anionic, zwitterionic surfactants, and mixtures thereof; preferably chosen from:
- amphoteric or zwitterionic surfactants, such as alkyl betaines, such as cocoyl betaine, lauryl betaine; alkylamphoacetates; cocamides;
- nonionic surfactants, such as fatty acid and polyol esters, and in particular glyceryl and fatty acid esters, such as the fatty acid ester PEG-6 Caprylic/capric glycerides; polycondensates, in particular polymers with oxyethylenated oxypropylene blocks such as Poloxamers; sorbitan fatty acid esters and their oxyethylenated derivatives, such as sorbitan monostearate; oxyethylene ethers of dihydrocholesterol; alkylpolyglycosides, in particular alkylpolyglucosides (APG) having an alkyl group comprising from 6 to 30 carbon atoms and preferably 8 to 16 carbon atoms, such as for example decylglucoside; caprylyl/capryl glucoside; laurylglucoside; and coco-glucoside;
- anionic surfactants, such as alkyl sulphates and their salts; alkyl ether sulphates and their salts, in particular their sodium salts, alkyl phosphates;
and their mixtures. 1Composition according to any one of the preceding claims, characterized in that the said at least one surfactant is chosen from: Sodium Laureth Sulfate, alkylpolyglucoside, lauryl ether carboxylic acid, polymer with polyoxyethylene blocks and polyoxypropylene blocks, such as poloxamer 184, surfactin sodium which is a lipopeptide composed of amino acids and fatty acids and is produced by the fermentation of Bacillus subtilis (INCI name Surfactin Sodium Salt), Cocobetaine, (Cocamidopropyl betaine), COCAMIDE MIPA (COPRAH ACID MONOISOPROPANOLAMIDE) , CETYL TRIMETHYL AMMONIUM CHLORIDE, COCO GLUCOSIDE, LAURETH-4, LAURETH-12, Laureth-5 carboxylic, Laury ether sulfate 2 EO, Disodium laureth sulfosuccinate, Olefin sulfonate, Ammonium lauryl sulfate, Sodium lauryl sulfate, Sodium lauroyl sarcosinate , Sodium Methyl Isethionate, Rhamnolipid, Lauric acid, Sodium Lauroyl lactylate, Cocobetaine, SODIUM (C14-16) OLEFIN SULFONATE, ALKYL (C8/C10/C12/C14 34/24/29/10) PO LYGLUCOSIDE (1,4), LAURIC ALCOHOL OXYETHYLENE (4 EO), LAURYL ETHER CARBOXYLIC ACID (4.5 EO), ALKYL (C8/C10 50/50) POLYGLUCOSIDE (2), LAURIC ALCOHOL OXYETHYLENE (12 EO), 1-HYDROXY- 4-METHYL 6-TRIMETHYLPENTYL 2-PYRIDONE, MONOETHANOLAMINE SODIUM LAUROYL METHYL ISETHIONATE SALT, ALKYL (C8/C16) POLYGLUCOSIDE (1.4), SODIUM (C14-16) OLEFIN SULFONATE ALKYL (C8/C10/C12/C14 34/24/ 29/10) POLYGLUCOSIDE, LAURIC ALCOHOL OXYETHYLENE (4 EO), ALKYL (C8/C10 50/50) POLYGLUCOSIDE (2); and mixtures of these surfactants. 2Composition according to any one of the preceding claims, characterized in that at least one surfactant is present in a content ranging from 0.1% by weight to 20% by weight, preferably from 0.2% by weight to 10% by weight , more preferably from 0.5% by weight to 8% by weight relative to the total weight of the composition. 3Composition according to any one of the preceding claims, characterized in that it has a turbidity of less than or equal to 300 NTU, preferably a turbidity in the range from 0.1 to 300 NTU, and preferably from 1 to 100 NTU . 4Antiperspirant and/or deodorant cosmetic product comprising a bottle containing an aqueous micellar composition according to any one of claims 1 to 13, and a dispensing pump and/or a spray device intended to dispense said aqueous micellar composition in the form a spray, in particular without greenhouse gas emissions from a liquefied hydrocarbon; said bottle preferably being transparent, preferably made of glass or plastic, such as PET. 5Process for the cosmetic treatment of body odors associated with human perspiration, in particular axillary odors, and possibly human perspiration, consisting in applying to the surface of the skin, in particular in the form of a spray, in particular using a pump or spray bottle, an effective amount of the cosmetic composition as defined according to any one of claims 1 to 13, in particular without greenhouse gas emission. A method according to claim 15, comprising agitating a composition according to any one of claims 1 to 13, before applying it, preferably by spraying or spraying, to the surface of the skin.